Stockscreener 앱 받기
48.62
3.99%
-2.02
Vera Therapeutics Inc 주식(VERA)의 최신 뉴스
Quarterly Earnings: Will Vera Therapeutics Inc stock attract ESG investors2025 Market Trends & Accurate Technical Buy Alerts - moha.gov.vn
Stock Traders Purchase Large Volume of Vera Therapeutics Call Options (NASDAQ:VERA) - MarketBeat
Vera Therapeutics stock drops 3% today as biotech slips into year-end trading - ts2.tech
Vera Therapeutics announces $200M public offering - MSN
Entry Recap: What risks investors should watch in Vera Therapeutics Inc stockJuly 2025 Momentum & Consistent Return Investment Signals - moha.gov.vn
Vera Therapeutics price target raised to $33 from $23 at Wedbush - MSN
50,000 Shares in Vera Therapeutics, Inc. $VERA Purchased by Swedbank AB - MarketBeat
450,700 Shares in Vera Therapeutics, Inc. $VERA Acquired by Capricorn Fund Managers Ltd - MarketBeat
Vera Therapeutics (VERA) Stock Dips in Thin Post‑Christmas Trading as Wall Street Weighs FDA Filing, $300M Raise, and IgA Nephropathy Competition - ts2.tech
Vera Therapeutics (NASDAQ:VERA) Sets New 1-Year HighShould You Buy? - MarketBeat
Vera Therapeutics Earnings Notes - Trefis
Trading Systems Reacting to (VERA) Volatility - Stock Traders Daily
Vera Therapeutics (VERA): Reassessing Valuation After Analyst Upgrades and Cash Boost for Atacicept Launch Prospects - Sahm
Vera Therapeutics Appoints James R. Meyers to Board - MSN
Vera’s New Capital Raise and Legal Transition Might Change The Case For Investing In Vera Therapeutics (VERA) - Sahm
How risky is Vera Therapeutics Inc. stock now2025 Market Overview & Smart Swing Trading Alerts - Улправда
Weekly Earnings: How Vera Therapeutics Inc. stock valuations compare to rivalsJuly 2025 EndofMonth & Momentum Based Trading Ideas - ulpravda.ru
Recap Report: Will Vera Therapeutics Inc. stock attract ESG investorsLong Setup & Long-Term Safe Investment Plans - moha.gov.vn
Vera Therapeutics, Inc. $VERA Shares Acquired by Squarepoint Ops LLC - MarketBeat
Goldman Sachs Maintains Vera Therapeutics (VERA) Buy Recommendation - Nasdaq
Vera Therapeutics stock hits 52-week high at 51.23 USD By Investing.com - Investing.com Nigeria
Vera Therapeutics (NASDAQ:VERA) Sets New 12-Month High Following Analyst Upgrade - MarketBeat
Vera Therapeutics Investors Drop Short-Swing Trading Lawsuit - Bloomberg Law News
Vera Therapeutics stock hits 52-week high at 51.23 USD - Investing.com
Vera Therapeutics (NASDAQ:VERA) Stock Price Expected to Rise, Bank of America Analyst Says - MarketBeat
Vera Therapeutics (NASDAQ:VERA) Given New $96.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Is Vera Therapeutics Inc. stock oversold or undervalued2025 Market Trends & Fast Gain Swing Alerts - Улправда
Is Vera Therapeutics Inc. stock gaining market shareProfit Target & Real-Time Buy Signal Notifications - DonanımHaber
Goldman Sachs raises Vera Therapeutics stock price target to $95 on IgAN pricing - Investing.com Canada
Vera Therapeutics stock price target raised to $66 by BofA Securities - Investing.com Canada
Will Vera Therapeutics Inc. stock maintain growth storyIndex Update & Weekly Breakout Watchlists - DonanımHaber
What risks investors should watch in Vera Therapeutics Inc. stockJuly 2025 Closing Moves & Daily Oversold Bounce Ideas - DonanımHaber
How Vera Therapeutics Inc. stock valuations compare to rivalsEarnings Recap Report & Low Volatility Stock Recommendations - Улправда
Aug Closing: How Vera Therapeutics Inc. stock valuations compare to rivalsShare Buyback & Daily Technical Forecast Reports - Улправда
Vera Therapeutics Announces Departure of Chief Legal Officer - TipRanks
Vera Therapeutics, Inc. Announces Departure of Jason Carter as Chief Legal Officer, Effective December 24, 2025 - marketscreener.com
Is Vera Therapeutics Inc. stock ready for breakoutJuly 2025 Update & Real-Time Price Movement Reports - Улправда
Vera Therapeutics Executive Sells 10,000 Shares - TradingView — Track All Markets
Vera Therapeutics Inc Stock Analysis and ForecastStock Screening Results & Small Entry Cost Portfolio - earlytimes.in
Latham & Watkins Represents Vera Therapeutics in US$300 Million Offering of Common Stock - Legal Desire Media and Insights
Hudson Bay Capital Management LP Acquires Shares of 298,976 Vera Therapeutics, Inc. $VERA - MarketBeat
Patrick Enright Acquires 5,882 Shares of Vera Therapeutics (NASDAQ:VERA) Stock - MarketBeat
Enright buys Vera Therapeutics (VERA) shares worth $249,985 By Investing.com - Investing.com Canada
Enright buys Vera Therapeutics (VERA) shares worth $249,985 - Investing.com
Vera Therapeutics Director Patrick G Enright Acquires 5,882 Shares - TradingView — Track All Markets
Dir Enright Buys 5,882 ($250K) Of Vera Therapeutics Inc [VERA] - TradingView — Track All Markets
Vera Therapeutics (VERA): Valuation Check After $260 Million Stock Offering Ahead of Atacicept FDA Decision - Sahm
Vera Therapeutics (NASDAQ:VERA) Trading Up 5.3%Still a Buy? - MarketBeat
Vera Therapeutics Sees Optimism as Analysts Boost Price Targets - timothysykes.com
Vera Therapeutics (NASDAQ:VERA) Hits New 12-Month HighHere's Why - MarketBeat
Avoiding Lag: Real-Time Signals in (VERA) Movement - news.stocktradersdaily.com
Vera Therapeutics, Inc. (NASDAQ:VERA) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Why Vera Therapeutics Stock Rocked the Market on Tuesday - MSN
Wedbush Maintains Vera Therapeutics (VERA) Neutral Recommendation - Nasdaq
Vera Therapeutics stock hits 52-week high at 47.12 USD By Investing.com - Investing.com Canada
0.57%
자본화:
|
볼륨(24시간):